Assignee
PATHIOS THERAPEUTICS LTD
GB·0 granted patents·7 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
7 records- 0164US2026070909A1Gpr65 modulatorsPATHIOS THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0254US2025304574A13,4,6,7-tetrahydro-2,7-naphthyridine-2(1h)-carboxamide derivatives as gpr65 inhibitors for the treatment of cancer and autoimmune diseasesPATHIOS THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0351US2024368173A1Tricyclic gpr65 modulatorsPATHIOS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0451US2024228494A1CompoundsPATHIOS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0546US2023373989A1N-phenylaminocarbonyl pyridino-, pyrimidino and benzo-tropanes as modulators of gpr65PATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0646US2024051961A1N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as gpr65 modulators for the treatment of cancerPATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0743US2023174530A1N-(phenylaminocarbonyl) tetrahydro-isoquinolines and related compounds as modulators of gpr65PATHIOS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PATHIOS THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →